Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2019-07, Vol.33 (7), p.1805-1810
Hauptverfasser:	Krombholz, Christopher F., Gallego-Villar, Lorena, Sahoo, Sushree S., Panda, Pritam K., Wlodarski, Marcin W., Aumann, Konrad, Hartmann, Mark, Lipka, Daniel B., Daskalakis, Michael, Plass, Christoph, Niemeyer, Charlotte M., Erlacher, Miriam, Flotho, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/70 64/60 692/308/2778 Animals Antimetabolites, Antineoplastic - pharmacology Azacitidine - pharmacology Cancer Research Carcinogenesis - drug effects Carcinogenesis - metabolism Carcinogenesis - pathology Critical Care Medicine Hematology Humans Intensive Internal Medicine Letter Leukemia Leukemia, Myelomonocytic, Juvenile - drug therapy Leukemia, Myelomonocytic, Juvenile - metabolism Leukemia, Myelomonocytic, Juvenile - pathology Medicine Medicine & Public Health Mesenchymal Stem Cells - drug effects Mesenchymal Stem Cells - metabolism Mesenchymal Stem Cells - pathology Mice Mice, Inbred BALB C Myelomonocytic leukemia Neoplastic Stem Cells - drug effects Neoplastic Stem Cells - metabolism Neoplastic Stem Cells - pathology Oncology Tumor Cells, Cultured Xenograft Model Antitumor Assays
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!